Bruker Corporation (NASDAQ:BRKR) reported its third-quarter earnings on Monday, beating Wall Street expectations, despite a decline in profit and revenue compared to the same period last year.

The company posted earnings of 45 cents per share, above analysts’ estimates of 34 cents, but down from 60 cents in the same period last year.

Revenue came in at $860.5 million, topping estimates of $848.7 million. Sales were down from $864.4 million in the same quarter last year.

Also Read: Bruker, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

Revenue growth from acquisitions contributed 1.1%, while foreign currency translation provided a favorable 2.9% year-on-year impact.

Bruker’s third-quarter 2025 GAAP financial results included non-cash impairment charges of $119.4 million related to goodwill and intangible assets, as well as restructuring charges of $34.5 million.

Adjusted gross profit margin stood at 50.1% and an adjusted operating income margin ...